Ovid Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Ovid Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ovid Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ovid Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $46k | 14k | 3.23 |
| 2023-09-30 | $52k | 13k | 3.88 |
| 2023-06-30 | $40k | 12k | 3.30 |
| 2023-03-31 | $71k | 28k | 2.58 |
| 2022-12-31 | $51k | 28k | 1.85 |
| 2022-03-31 | $119k | 38k | 3.13 |
| 2021-12-31 | $122k | 38k | 3.21 |
| 2021-09-30 | $128k | 38k | 3.37 |
| 2021-06-30 | $148k | 38k | 3.90 |
| 2021-03-31 | $148k | 37k | 4.03 |
| 2018-06-30 | $1.4M | 185k | 7.80 |
| 2018-03-31 | $2.1M | 301k | 7.07 |
| 2017-12-31 | $3.0M | 300k | 9.87 |
| 2017-06-30 | $3.6M | 362k | 10.06 |